Advanced search

Total mesorectal excision in the treatment of rectal cancer: a review

Wim Ceelen (UGent) and Piet Pattyn (UGent)
(2000) ACTA CHIRURGICA BELGICA. 100(3). p.94-99
Author
Organization
Abstract
Despite the improvements in preoperative staging, surgical technique and adjuvant therapy, local recurrence remains a significant problem in rectal cancer surgery. Several patient- and tumour-related risk factors for the development of local recurrence have been identified and are being addressed by regimens of pre- or postoperative adjuvant therapy. Total mesorectal excision (TME) recently has been shown to result in a low recurrence rate even without the use of adjuvant therapy. Nevertheless, conclusive evidence in the form of a prospective randomized trial is to date not available. This paper describes the technique of TME and reviews the clinical and pathological data supporting its use in rectal cancer surgery.
Keywords
mesorectum, rectal cancer, surgery, therapy, LOCAL RECURRENCE, ANTERIOR RESECTION, COLORECTAL-CANCER, SURGICAL-TREATMENT, PELVIC RECURRENCE, LOW ANASTOMOSIS, SURVIVAL RATES, TUMOR SPREAD, CARCINOMA, SURGERY

Citation

Please use this url to cite or link to this publication:

Chicago
Ceelen, Wim, and Piet Pattyn. 2000. “Total Mesorectal Excision in the Treatment of Rectal Cancer: a Review.” Acta Chirurgica Belgica 100 (3): 94–99.
APA
Ceelen, Wim, & Pattyn, P. (2000). Total mesorectal excision in the treatment of rectal cancer: a review. ACTA CHIRURGICA BELGICA, 100(3), 94–99.
Vancouver
1.
Ceelen W, Pattyn P. Total mesorectal excision in the treatment of rectal cancer: a review. ACTA CHIRURGICA BELGICA. 2000;100(3):94–9.
MLA
Ceelen, Wim, and Piet Pattyn. “Total Mesorectal Excision in the Treatment of Rectal Cancer: a Review.” ACTA CHIRURGICA BELGICA 100.3 (2000): 94–99. Print.
@article{172133,
  abstract     = {Despite the improvements in preoperative staging, surgical technique and adjuvant therapy, local recurrence remains a significant problem in rectal cancer surgery.
Several patient- and tumour-related risk factors for the development of local recurrence have been identified and are being addressed by regimens of pre- or postoperative adjuvant therapy.
Total mesorectal excision (TME) recently has been shown to result in a low recurrence rate even without the use of adjuvant therapy. Nevertheless, conclusive evidence in the form of a prospective randomized trial is to date not available.
This paper describes the technique of TME and reviews the clinical and pathological data supporting its use in rectal cancer surgery.},
  author       = {Ceelen, Wim and Pattyn, Piet},
  issn         = {0001-5458},
  journal      = {ACTA CHIRURGICA BELGICA},
  keyword      = {mesorectum,rectal cancer,surgery,therapy,LOCAL RECURRENCE,ANTERIOR RESECTION,COLORECTAL-CANCER,SURGICAL-TREATMENT,PELVIC RECURRENCE,LOW ANASTOMOSIS,SURVIVAL RATES,TUMOR SPREAD,CARCINOMA,SURGERY},
  language     = {eng},
  number       = {3},
  pages        = {94--99},
  title        = {Total mesorectal excision in the treatment of rectal cancer: a review},
  volume       = {100},
  year         = {2000},
}

Web of Science
Times cited: